FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896020003> ?p ?o ?g. }

• W2896020003 endingPage "e0204610" @default.
• W2896020003 startingPage "e0204610" @default.
• W2896020003 abstract "Background Pulmonary hypertension (PH) due to left heart failure (HF) is the most common form of PH. However, treatment is unclear because there are conflicting results about safety and efficacy of PH-targeted therapies. Objectives To assess the effects of PH-targeted therapy on exercise capacity in HF patients. Methods MEDLINE, EMBASE and the Cochrane Library were searched from January 1990 to July 2017 for randomized controlled trials comparing PH-targeted therapies to conventional therapy in HF. The primary outcome was to assess the effects on exercise capacity. Secondary outcomes included mortality, hospitalisation, NT-proBNP levels, echocardiographic and hemodynamics parameters and discontinuation rate. Results 22 studies were included (n = 5448), including 3, 8 and 11 studies with low, high and unknown risk of bias, respectively. PH-targeted therapies were associated with an improvement of exercise capacity (standardized mean difference 0.29;95%CI:0.08–0.50, p = 0.006). Pre-specified subgroup analyses found that this improvement was predominantly observed in studies evaluating phosphodiesterase-5 inhibitors and prostanoids and in patients with reduced ejection fraction. Moreover, systolic pulmonary artery pressure measured by echocardiography was improved (mean difference: -7.5mmHg; [95%CI]: -14.9,-0.1, p = 0.05), which was also entirely driven by studies evaluating phosphodiesterase-5 inhibitors. However, PH-targeted therapies were associated with an increased treatment discontinuation rates and a potential increase in mortality compared to standard treatment. Conclusions In conclusion, PH-targeted therapies and especially phosphodiesterase-5 inhibitors may improve exercise capacity in patients with HF. However, an increase in adverse outcomes was likely. Moreover, most studies were at high or unknown risk of bias, precluding confident conclusions about the effects of PH-targeted therapies." @default.
• W2896020003 created "2018-10-26" @default.
• W2896020003 creator A5024237064 @default.
• W2896020003 creator A5045417032 @default.
• W2896020003 creator A5045468605 @default.
• W2896020003 creator A5048736345 @default.
• W2896020003 creator A5056129436 @default.
• W2896020003 creator A5068827777 @default.
• W2896020003 creator A5071652252 @default.
• W2896020003 date "2018-10-11" @default.
• W2896020003 modified "2023-10-16" @default.
• W2896020003 title "Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis" @default.
• W2896020003 cites W120579310 @default.
• W2896020003 cites W122121821 @default.
• W2896020003 cites W1499596446 @default.
• W2896020003 cites W1596958248 @default.
• W2896020003 cites W1914155053 @default.
• W2896020003 cites W1975943347 @default.
• W2896020003 cites W1992255464 @default.
• W2896020003 cites W2005501262 @default.
• W2896020003 cites W2013848755 @default.
• W2896020003 cites W2028148874 @default.
• W2896020003 cites W2033852098 @default.
• W2896020003 cites W2038634091 @default.
• W2896020003 cites W2055751817 @default.
• W2896020003 cites W2075941589 @default.
• W2896020003 cites W2084160023 @default.
• W2896020003 cites W2084499057 @default.
• W2896020003 cites W2090096657 @default.
• W2896020003 cites W2098923148 @default.
• W2896020003 cites W2104847567 @default.
• W2896020003 cites W2113835063 @default.
• W2896020003 cites W2117239217 @default.
• W2896020003 cites W2119436573 @default.
• W2896020003 cites W2122188617 @default.
• W2896020003 cites W2122984949 @default.
• W2896020003 cites W2129800911 @default.
• W2896020003 cites W2131788441 @default.
• W2896020003 cites W2138091764 @default.
• W2896020003 cites W2142525108 @default.
• W2896020003 cites W2148326029 @default.
• W2896020003 cites W2152940522 @default.
• W2896020003 cites W2161370807 @default.
• W2896020003 cites W2163360308 @default.
• W2896020003 cites W2166504467 @default.
• W2896020003 cites W2170892587 @default.
• W2896020003 cites W2183644045 @default.
• W2896020003 cites W2209002211 @default.
• W2896020003 cites W2288033263 @default.
• W2896020003 cites W2294914721 @default.
• W2896020003 cites W2526299174 @default.
• W2896020003 cites W2564148032 @default.
• W2896020003 cites W2582602949 @default.
• W2896020003 cites W2588681363 @default.
• W2896020003 cites W2602812050 @default.
• W2896020003 cites W2603535098 @default.
• W2896020003 cites W2607845025 @default.
• W2896020003 cites W2608302158 @default.
• W2896020003 cites W2611961151 @default.
• W2896020003 cites W2618258608 @default.
• W2896020003 cites W2627078014 @default.
• W2896020003 cites W2754703030 @default.
• W2896020003 cites W2758173942 @default.
• W2896020003 cites W2786647296 @default.
• W2896020003 cites W2806263607 @default.
• W2896020003 doi "https://doi.org/10.1371/journal.pone.0204610" @default.
• W2896020003 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6181322" @default.
• W2896020003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30307953" @default.
• W2896020003 hasPublicationYear "2018" @default.
• W2896020003 type Work @default.
• W2896020003 sameAs 2896020003 @default.
• W2896020003 citedByCount "11" @default.
• W2896020003 countsByYear W28960200032019 @default.
• W2896020003 countsByYear W28960200032020 @default.
• W2896020003 countsByYear W28960200032021 @default.
• W2896020003 countsByYear W28960200032022 @default.
• W2896020003 countsByYear W28960200032023 @default.
• W2896020003 crossrefType "journal-article" @default.
• W2896020003 hasAuthorship W2896020003A5024237064 @default.
• W2896020003 hasAuthorship W2896020003A5045417032 @default.
• W2896020003 hasAuthorship W2896020003A5045468605 @default.
• W2896020003 hasAuthorship W2896020003A5048736345 @default.
• W2896020003 hasAuthorship W2896020003A5056129436 @default.
• W2896020003 hasAuthorship W2896020003A5068827777 @default.
• W2896020003 hasAuthorship W2896020003A5071652252 @default.
• W2896020003 hasBestOaLocation W28960200031 @default.
• W2896020003 hasConcept C126322002 @default.
• W2896020003 hasConcept C164705383 @default.
• W2896020003 hasConcept C168563851 @default.
• W2896020003 hasConcept C197934379 @default.
• W2896020003 hasConcept C2776478404 @default.
• W2896020003 hasConcept C2778198053 @default.
• W2896020003 hasConcept C2778715236 @default.
• W2896020003 hasConcept C2780930700 @default.
• W2896020003 hasConcept C71924100 @default.
• W2896020003 hasConcept C78085059 @default.
• W2896020003 hasConcept C95190672 @default.
• W2896020003 hasConceptScore W2896020003C126322002 @default.

• next